The question is not whether AI will transform healthcare; it’s whether regulators can keep pace with that transformation.

The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical ...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...

In another rebuke to federal regulatory overreach, the U.S. District Court for the Eastern District of Texas (“District Court ...

FORT LAUDERDALE, FL / ACCESS Newswire / April 18, 2025 / EndoUVtech, a pioneering medical device company dedicated to transforming surgical stroke patient outcomes, today announced a crucial step in ...

Drug Regulatory Body: "This action of identifying NSQ and Spurious medicines is taken on a regular basis in collaboration ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies are disrupting the work of drug, ...

The Food and Drug Administration’s (FDA) recent rejection of all study data from Mid-Link Testing highlights the importance of using reliable, ...

Precision Neuroscience has received FDA approval for a key component of its brain-computer interface, aimed at restoring ...

After mass layoffs, the FDA has started missing certain deadlines, pushing one biopharma to delay a phase 3 trial and ...